Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 AB INBEV ABI 18. nov 2025 52.62 -2.41   
 ABO-Group Environment NV ABO 18. nov 2025 5.80 -0.85   
 Accentis NV ACCB 18. nov 2025 0.03 0.00   
 Ackermans & van Haaren NV ACKB 18. nov 2025 217.40 -2.07   
 Aedifica SA AED 18. nov 2025 66.50 -0.52   
 Ageas AGS 18. nov 2025 57.60 -1.03   
 Agfa-Gevaert NV AGFB 18. nov 2025 0.63 -13.10   
 AHOLD DEL AD 18. nov 2025 35.49 -1.25   
 APERAM APAM 18. nov 2025 30.62 -0.26   
 Argen X SE ARGX 18. nov 2025 788.60 -0.48   
 Ascencio Sca ASCE 18. nov 2025 50.50 0.00   
 Atenor ATEB 18. nov 2025 2.64 0.00   
 AVANTIUM AVTX 18. nov 2025 6.25 +0.24   
 Azelis Group NV AZE 18. nov 2025 9.33 +1.03   
 Banco Bilbao Vizcaya Argentaria SA BBV 18. nov 2025 7.80 0.00   
 Banco Santander SA SANTA 18. nov 2025 3.58 0.00   
 Banimmo SA BANI 18. nov 2025 2.90 -0.68   
 Banque Nationale de Belgique BNB 18. nov 2025 416.00 +1.96   
 BANQUP GROUP BANQ 18. nov 2025 3.37 -7.16   
 Barco NV BAR 18. nov 2025 12.16 -1.54   
 Basilix BAS 18. nov 2025 27.80 0.00   
 Beaulieu Av Certificates BEAB 18. nov 2025 1.19 0.00   
 Befimmo SA BEFB 18. nov 2025 46.10 0.00   
 Bel20 BEL20 18. nov 2025 4 943.78 -1.54   
 Belreca - Belgian Resources and Capital Company BELR 18. nov 2025 7.50 0.00   
 Beluga NV BELU 18. nov 2025 0.18 0.00   
 Belysse Group N.V. BELYS 18. nov 2025 0.90 +0.56   
 Biocartis Group NV BCART 18. nov 2025 0.29 0.00   
 Biosenic BIOS 18. nov 2025 0.00 +4.35   
 Biotalys BTLS 18. nov 2025 4.76 -2.46   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.